Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that it enclosed copy of notice published in Economic Times (English) & Navshakti (Marathi) newspaper, on Wednesday, 21st December 2022 inviting attention of concerned shareholders to lodge their claims in respect of unclaimed dividends of the Company for last seven years, failing which their shares would be transferred to Investor Education and Protection Fund ('IEPF') account, in accordance with section 124(6) of the Companies Act, 2013 read with Rules.
The above information is a part of company’s filings submitted to BSE.
